Reported sales nil
Net loss of Biogen Pharmachem Industries reported to Rs 0.23 crore in the quarter ended March 2022 as against net profit of Rs 0.62 crore during the previous quarter ended March 2021. There were no Sales reported in the quarter ended March 2022 as against Rs 1.62 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 0.01 crore in the year ended March 2022 as against net loss of Rs 1.60 crore during the previous year ended March 2021. Sales rose 52.47% to Rs 2.47 crore in the year ended March 2022 as against Rs 1.62 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales01.62 -100 2.471.62 52 OPM %038.27 --0.81-98.77 - PBDT-0.230.62 PL -0.01-1.60 99 PBT-0.230.62 PL -0.01-1.60 99 NP-0.230.62 PL -0.01-1.60 99
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
